Possible scenario
Deals Broaden
20% Chance
The administration uses the $64 billion state-savings announcement as leverage to push more manufacturers into Pfizer-style direct pricing and rebate deals. The market treats this as confirmation that most-favored-nation benchmarks are becoming a durable sector framework.
Secondary impacts
- Healthcare -2.3%
Tickers
- LLY-2.7%
- MRK-1.8%
- PFE-1.3%
- JNJ-1.3%
- AMGN-1.1%
- -1.0%
Portfolio impact
S&P 500-0.2%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.